Kemira Oyj (HEL:KEMIRA)
Finland · Delayed Price · Currency is EUR | Market Cap | 2.92B |
| Revenue (ttm) | 2.85B |
| Net Income (ttm) | 224.50M |
| Shares Out | 153.98M |
| EPS (ttm) | 1.45 |
| PE Ratio | 13.08 |
| Forward PE | 11.81 |
| Dividend | 0.74 (3.91%) |
| Ex-Dividend Date | Oct 27, 2025 |
| Volume | 24,568 |
| Average Volume | 194,850 |
| Open | 19.04 |
| Previous Close | 18.96 |
| Day's Range | 19.04 - 19.30 |
| 52-Week Range | 16.95 - 23.08 |
| Beta | 0.51 |
| RSI | 51.35 |
| Earnings Date | Jul 18, 2025 |
About Silk Road Medical
Kemira Oyj operates as a chemicals company in Finland, rest of Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates in two segments, Pulp & Paper and Industry & Water. The Pulp & Paper segment develops and commercializes pulp and paper, as well as a range of products for paper wet-end, including packaging, board, and tissue products. The Industry & Water segment offers coagulants, polymers, and other water treatment chemicals. Kemira Oyj was founded in 1920 and is headquartered in Helsinki, Finland. [Read more]
Financial Performance
In 2024, Kemira Oyj's revenue was 2.95 billion, a decrease of -12.92% compared to the previous year's 3.39 billion. Earnings were 249.40 million, an increase of 25.26%.
Financial StatementsNews
Kemira: Long-Term Growth Potential Remains Intact
Kemira: Long-Term Growth Potential Remains Intact
Kemira: A Stronger Than Anticipated Result After Selling The O&G Division
Kemira's Q2 results were robust despite selling its oil and gas division, with net income of 62M EUR and EPS of 0.40 EUR. Adjusted operating cash flow for H1 was 220M EUR, with free cash flow of 168M ...